5 min - BioSense Team - 2026-06-24
- level:understanding
- valeurs de référence
- bilan sanguin
- normes laboratoire
- interprétation
Blood test reference ranges, the "normal" values printed next to each result, usually describe the interval containing the middle 95% of a healthy group. They are statistical reference points, not personal targets, so a result "within range" is not always enough. This article explains where these ranges come from, why they don't fit everyone, and how to reread your lab results in light of your own situation.
You open your lab results in the patient portal. Everything is "within range": no flag, no red number, no alert. Relief. And yet you've felt tired for weeks, you've gained weight for no clear reason, or your doctor said a value needs "monitoring" without saying more.
The reason for this gap is simple, and it's rarely explained: the reference ranges on a lab report are built from a population, not for you. Understanding what they are, and what they aren't, changes the way you read your blood test.
What do normal blood test ranges mean, and where do they come from?
Reference ranges, also called reference intervals or normal values, are based on test results from groups of healthy people, as MedlinePlus explains. The usual method measures a marker in that group and keeps the central 95% of the results. The lowest 2.5% and the highest 2.5% fall outside the range by convention.
Ideally, a lab would test at least 120 healthy people in each relevant group. A 2025 review in the Journal of the American Board of Family Medicine notes that this is often impractical, so many ranges are adopted from historic standards, textbooks or test manufacturers.
This definition has two direct consequences. First, by construction, about 5% of healthy people are labeled "out of range" on any one test without there being a problem. Second, MedlinePlus points out that a result within the range isn't a guarantee of good health: some people with health problems have "normal" results. A statistical range is neither a treatment target nor a clinical alert threshold.
Reference ranges also vary from one lab to another. In the US, federal CLIA rules require a lab to make its reference intervals available to the person who ordered the test, as determined by the lab performing it. The population used, the testing method and the instruments all explain differences. This is why some results aren't directly comparable between labs, especially if you switch between tests.
Key point - A lab "range" is a statistical interval calculated on a reference population. It is neither a personal target nor a clinical threshold, and it varies from one lab to another.
Three limits of blood test reference ranges
1. Reference ranges may not reflect your profile
Many ranges are general adult ranges. Yet your age, your sex, your ancestry, and your personal and family history can all change what is relevant for you. A creatinine of 1.0 mg/dL (88 µmol/L) gives an estimated GFR of about 95 in a 45-year-old man using the race-free CKD-EPI 2021 equation, and about 59 in a 75-year-old woman. Same number, a different reading. An eGFR below 60 that lasts more than 3 months is one of the criteria for chronic kidney disease in the KDIGO guideline, so the second result would call for a follow-up.
2. Reference ranges ignore your lifestyle
Your current medications, physical activity, diet, stress, sun exposure and life stage (perimenopause, postpartum) can influence your biomarkers. After strenuous exercise, creatine kinase (CK) can rise far above the printed range and take about a week to come down. Reading these values out of context means missing the real signal.
3. Reference range and treatment target: two different things
This is probably the most frequent confusion. Clinical guidelines define treatment goals based on your risk, and those goals don't appear in a generic range.
LDL cholesterol is the clearest example. An LDL of 85 mg/dL (2.2 mmol/L) may carry no flag at all. Yet the 2026 ACC/AHA guideline sets a goal below 100 mg/dL (2.6 mmol/L) at borderline or intermediate risk, below 70 mg/dL (1.8 mmol/L) at high risk, and below 55 mg/dL (1.4 mmol/L) for very high-risk cardiovascular disease. The same result can be on target for one person and well above target for another. European guidelines (ESC/EAS 2019) also sort goals by risk, with a low-risk goal below 116 mg/dL (3.0 mmol/L).
Key point - A lab range isn't adapted to your profile or your lifestyle, and it isn't the same as a treatment target. Those are three blind spots to know about when you read your results.
Three examples where "within range" isn't enough
Ferritin at 25 ng/mL (25 µg/L): normal, but perhaps low for you
MedlinePlus gives a normal ferritin range of 13 to 150 ng/mL (13 to 150 µg/L) for women and 30 to 400 ng/mL (30 to 400 µg/L) for men, and notes that the lower the level, even within the normal range, the more likely iron stores are low. A ferritin of 25 ng/mL (25 µg/L) may therefore appear normal. For a 48-year-old in perimenopause with heavy periods and three months of fatigue, it deserves a closer look.
Thresholds differ depending on the question being asked. The WHO uses below 15 µg/L (15 ng/mL) to define iron deficiency in apparently healthy adults. The American Gastroenterological Association (2020) uses below 45 ng/mL (45 µg/L) to diagnose iron deficiency in people who have anemia. Your doctor will read the number alongside your hemoglobin, symptoms and any inflammation, which can raise ferritin.
TSH at 4 mIU/L: high-normal, to be read according to your age and symptoms
MedlinePlus gives a normal TSH range of 0.4 to 4.8 µU/mL (the same as mIU/L) and notes that experts don't fully agree on the upper limit. The 2012 AACE/ATA guideline says an upper limit of 4.12 mIU/L should be considered when an age-based limit isn't available. A TSH of 4 mIU/L is therefore "within range" on most reports. With fatigue, feeling cold or unexplained weight gain, it is still worth discussing, particularly if thyroid antibodies are present.
Age matters too. In the large US NHANES survey, the upper limit of TSH (97.5th percentile) rose from 3.56 mIU/L at ages 20 to 29 to 7.49 mIU/L at age 80 and older. A TSH of 4 mIU/L at 50 and at 80 therefore doesn't tell the same story.
A1C at 5.9% (41 mmol/mol): prediabetes in the US, not in the UK
How an A1C of 5.9% (41 mmol/mol) is flagged depends on your lab and on the threshold it prints. The American Diabetes Association (ADA) defines prediabetes as an A1C of 5.7% to 6.4% (39 to 46 mmol/mol). In the UK, NICE uses 6.0% to 6.4% (42 to 47 mmol/mol) to define high risk. At 5.9%, you are therefore in the ADA's prediabetes zone, which calls for attention to lifestyle and follow-up, but just below the NICE threshold. A guideline threshold and a printed range do not always say the same thing.
Key point - Ferritin, TSH, A1C: three examples where the range on a report can differ from what is clinically relevant for you. The conversation with your doctor starts there.
The BioSense method
This is exactly where BioSense comes in. Rather than rereading your results out of context, the service cross-references each biomarker with your health questionnaire: age, sex, personal and family history, lifestyle, current medications, reason for the test, any symptoms. Your results are also tracked over time, to spot a drift early.
*ChatGPT answers you. BioSense knows you.* *BioSense, your prevention companion.* BioSense does not provide a diagnosis and does not replace your doctor. It is a prevention companion that helps you understand, ask the right questions and act day to day.
Reference ranges: three questions to ask your doctor
If some of your results are "within range" but symptoms persist, here are three questions to prepare for your next visit:
- My results are within the lab's range, but are they within the treatment goal recommended for my profile?
- Given my history and my lifestyle, do any "borderline" values deserve a closer look?
- When should these values be rechecked, and at which lab so that the results are comparable?
This preparation steers the visit toward what really matters: the consistency between your numbers, your profile and the clinical guidelines.
Frequently asked questions
What is a reference range on a blood test?
A reference range is usually the interval containing the middle 95% of results in a group considered healthy. It is a reference point for placing your result. It does not, on its own, say whether that result suits your situation.
What are normal blood test values?
There is no single set of normal values: each marker has its own range, and it varies by lab. Always compare a result with the range printed on its own report, rather than with figures found online.
Why do reference ranges differ between labs?
They depend on the reference population, the testing method and the instrument used. That is why reports from two different labs cannot always be compared directly.
Is a result just outside the range serious?
Not necessarily: by construction, about 5% of healthy people fall outside the range for each test. Your doctor reads the difference together with your profile, your symptoms and your previous tests.
Import your blood test into BioSense and receive a plain-language reading of each of your biomarkers, placed in the context of your personal profile and tracked over time. Your data is hosted on servers located in France.
[→ Import my report](/en/onboarding/upload)
Sources and methodology
International
- World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations, 2020.
- KDIGO. 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.
United States
- MedlinePlus (National Library of Medicine). How to understand your lab results.
- MedlinePlus. Ferritin blood test.
- MedlinePlus. TSH test.
- Doles N, et al. Interpretating normal values and reference ranges for laboratory tests. J Am Board Fam Med 2025;38(1):174-179.
- Code of Federal Regulations. 42 CFR 493.1291, Standard: Test report (CLIA).
- Blumenthal RS, et al. 2026 ACC/AHA multisociety guideline on the management of dyslipidemia. J Am Coll Cardiol 2026;87(19):2624-2757. ACC summary.
- American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2026. Diabetes Care 2026;49(Suppl 1):S27-S49.
- NIDDK. The A1C test and diabetes.
- Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults (AACE/ATA). Thyroid 2012;22(12):1200-1235.
- Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population. J Clin Endocrinol Metab 2007;92(12):4575-4582.
- Ko CW, et al. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology 2020;159(3):1085-1094.
- Delgado C, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force. Am J Kidney Dis 2022;79(2):268-288.
- Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med 2016;83(1):37-42.
United Kingdom
- National Institute for Health and Care Excellence (NICE). Type 2 diabetes: prevention in people at high risk (public health guideline PH38, 2012, updated 2017).
Europe
- Mach F, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2020;41(1):111-188, and 2025 focused update.
*BioSense methodology: our content is based on guidance from US authorities and medical societies (such as the USPSTF, CDC, NIH, FDA, ACC/AHA and ADA), UK bodies (NICE, NHS), European societies and the WHO. Sources are listed by country, and differences between countries are stated when they matter.*
Going further
*This article is for informational purposes only and is neither medical advice nor a diagnosis. For any questions about your health, consult your doctor.*